Gene · 5464
Papers3,642
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,642
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Overlap Analysis Identifies a Shared Etiology between Migraine and Headache with Type 2 Diabetes. | Genes (Basel) | 2022 | 36292730 | PubTator, text mining | PubMed |
| Targeting NMDA Receptors in Emotional Disorders: Their Role in Neuroprotection. | Brain Sci | 2022 | 36291261 | PubTator, text mining | PubMed |
| Is IIIG9 a New Protein with Exclusive Ciliary Function? Analysis of Its Potential Role in Cancer and Other Pathologies. | Cells | 2022 | 36291193 | PubTator, text mining | PubMed |
| Principles and Applications of Loop-Mediated Isothermal Amplification to Point-of-Care Tests. | Biosensors (Basel) | 2022 | 36290994 | PubTator, text mining | PubMed |
| Inverse In Vitro Selection Enables Comprehensive Analysis of Cross-Chiral L-Aptamer Interactions. | Chembiochem | 2022 | 36282114 | PubTator, text mining | PubMed |
| PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway. | Int J Oncol | 2022 | 36263632 | PubTator, text mining | PubMed |
| Molecular architecture of the glycogen- committed PP1/PTG holoenzyme. | Nat Commun | 2022 | 36261419 | PubTator, text mining | PubMed |
| Study on the mechanism of scutellarin's protective effect against ZEA-induced mouse ovarian granulosa cells injury. | Food Chem Toxicol | 2022 | 36252740 | PubTator, text mining | PubMed |
| The two facets of receptor tyrosine kinase in cardiovascular calcification-can tyrosine kinase inhibitors benefit cardiovascular system? | Front Cardiovasc Med | 2022 | 36237897 | PubTator, text mining | PubMed |
| Quantitative downhill skiing technique analysis according to ski instruction curricula: A proof-of-concept study applying principal component analysis on wearable sensor data. | Front Bioeng Biotechnol | 2022 | 36237214 | PubTator, text mining | PubMed |
| Head-to-Tail and Head-to-Head Molecular Chains of Poly(p-Anisidine): Combined Experimental and Theoretical Evaluation. | Molecules | 2022 | 36234863 | PubTator, text mining | PubMed |
| A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | Int J Mol Sci | 2022 | 36232890 | PubTator, text mining | PubMed |
| Advances in Dietary Phenolic Compounds to Improve Chemosensitivity of Anticancer Drugs. | Cancers (Basel) | 2022 | 36230494 | PubTator, text mining | PubMed |
| A nine-consensus-prognostic -gene-based prognostic signature, recognizing the dichotomized subgroups of gastric cancer patients with different clinical outcomes and therapeutic strategies. | Front Genet | 2022 | 36226177 | PubTator, text mining | PubMed |
| Sharing the wealth: The versatility of proteins targeted to peroxisomes and other organelles. | Front Cell Dev Biol | 2022 | 36225313 | PubTator, text mining | PubMed |
| Spike S1 domain interactome in non-pulmonary systems: A role beyond the receptor recognition. | Front Mol Biosci | 2022 | 36225252 | PubTator, text mining | PubMed |
| Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways. | Mol Cancer | 2022 | 36221123 | PubTator, text mining | PubMed |
| Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer. | Nat Commun | 2022 | 36207308 | PubTator, text mining | PubMed |
| Nuclear Inhibitor of Protein Phosphatase 1 (NIPP1) Regulates CNS Tau Phosphorylation and Myelination During Development. | Mol Neurobiol | 2022 | 36198882 | PubTator, text mining | PubMed |
| De novo variants are a common cause of genetic hearing loss. | Genet Med | 2022 | 36194208 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5464/papers?page=20